Successful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patient

dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridHarputluoglu, Muhsin Murat Muhip/0000-0002-9415-147X
dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.authorwosidHarputluoglu, Muhsin Murat Muhip/ABI-3094-2020
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.contributor.authorAkbulut, Sami
dc.contributor.authorHarputluoglu, Murat
dc.contributor.authorYilmaz, Sezai
dc.date.accessioned2024-08-04T20:45:26Z
dc.date.available2024-08-04T20:45:26Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe risk of de novo hepatitis B virus infection is lower after liver transplant using hepatitis B core antibody-negative donors into negative recipients versus hepatitis B core antibody-positive donors but can occur. Here, we present a 34-year-old male patient with acute de novo hepatitis B virus that developed 7 months after successful liver transplant. The case we report here is the first in the literature with regard to both switch from tenofovir to entecavir treatment and the presentation of de novo acute hepatitis B virus after liver transplant. The switch in treatment protocol resulted in significant improvements in serologic and biochemical levels, and the patient was discharged from the hospital on day 35 after admittance.en_US
dc.identifier.doi10.6002/ect.2018.0072
dc.identifier.endpage637en_US
dc.identifier.issn1304-0855
dc.identifier.issue5en_US
dc.identifier.pmid29790455en_US
dc.identifier.scopus2-s2.0-85054093893en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage635en_US
dc.identifier.urihttps://doi.org/10.6002/ect.2018.0072
dc.identifier.urihttps://hdl.handle.net/11616/98482
dc.identifier.volume16en_US
dc.identifier.wosWOS:000451460400024en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherBaskent Univen_US
dc.relation.ispartofExperimental and Clinical Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute liver failureen_US
dc.subjectEntecaviren_US
dc.subjectFulminant diseaseen_US
dc.subjectTenofoviren_US
dc.titleSuccessful Management of De Novo Acute Hepatitis B Virus Infection With Entecavir in a Living-Donor Liver Transplant Patienten_US
dc.typeArticleen_US

Dosyalar